Answers are grounded in this paper and cite their sources.
A dual polymerase chain reaction (PCR) technique is developed which enables the detection of one part male DNA in 25,000 parts female DNA. The technique amplifies a part of the X-Y homologous amelogenin gene in which the Y counterpart has a 189 bp deletion within one of the introns. This deletion has made it possible to identify individual X and Y counterparts based on the difference in size between them. None of the 18 pregnant women studied showed a positive Y-signal although eight of them bear male fetuses excluding the presence of fetal cells at one in 25,000 maternal cells. The results presented here show that a sensitivity of greater than one in 25,000 is required for detection of fetal genetic disease using maternal peripheral blood.
No takes yet. Share an insight, caveat, or question.
Nakagome et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: